(Bloomberg) -- Life-sciences company Danaher Corp. has stopped pursuing Catalent Inc. after expressing interest in buying the contract manufacturer, according to people familiar with the matter.
Life-sciences company Danaher Corporation (NYSE: DHR) is reportedly no longer considering a takeover of contract manufacturer Catalent Inc (NYSE: CTLT) after expressing interest in buying the ...
Days later, Bloomberg reported that Danaher Corp. was no longer considering a takeover of Catalent, according to people familiar with the situation. Danaher had earlier made overtures to the ...
Never miss a trade again with the fastest news alerts in the world! This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday. Want ...
Pall Corp. (PLL) stock is rising after the company said it will be acquired by Danaher (DHR) for $13.8 billion. Pall Corp. (PLL) stock is rising after the company said it will be acquired by ...
Wells Fargo's upgrade Tuesday also comes a day after Danaher reportedly ended a potential bid to acquire contract manufacturer Catalent (CTLT), according to Bloomberg, citing people familiar with ...
Catalent is a partner for pharmaceutical and biotechnology companies, helping its customers to bring products to the market in a faster fashion. The company does this by providing oral, injectable ...
Maravai LifeSciences Holdings Inc MRVI reportedly attracted takeover interest from Thomas ... appointed William "Trey" Martin III, a former Danaher executive, as its new CEO.
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments ...
